Literature DB >> 22863327

Chronic venous leg ulcers: the future of cell-based therapies.

Matthias Augustin1, Wolfgang Vanscheidt.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22863327     DOI： 10.1016/S0140-6736(12)61255-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Cost-effectiveness of treating vascular leg ulcers with UrgoStart(®) and UrgoCell(®) Contact.

Authors:  Matthias Augustin; Katharina Herberger; Knut Kroeger; Karl C Muenter; Lisa Goepel; Reinhard Rychlik
Journal:  Int Wound J       Date:  2014-02-21       Impact factor: 3.315

2.  Effectiveness of an acellular synthetic matrix in the treatment of hard-to-heal leg ulcers.

Authors:  Keith Harding; Pat Aldons; Helen Edwards; Michael Stacey; Kathleen Finlayson; Michelle Gibb; Liz Jenkins; Gary Shooter; Derek Van Lonkhuyzen; Emily Lynam; Eva-Lisa Heinrichs; Zee Upton
Journal:  Int Wound J       Date:  2013-07-09       Impact factor: 3.315

3.  Hyaluronic Acid Sodium Salt 0.2% Gel in the Treatment of a Recalcitrant Distal Leg Ulcer: A Case Report.

Authors:  Mario Tagliagambe; Tuan A Elstrom; Daniel B Ward
Journal:  J Clin Aesthet Dermatol       Date:  2017-11-01

4.  [Challenges of aging skin: Care and therapy using the example of venous ulcers].

Authors:  M Augustin; G Mayer; T Wild
Journal:  Hautarzt       Date:  2016-02       Impact factor: 0.751
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.